Metabolism of coumarin by rat, gerbil and human liver microsomes

References

• Bruce J. M., Creed D. Light-induced and related reactions of quinones. Part VI. Reactions of some p-quinones carrying formyl groups. Journal of the Chemical Society, C 1970; 649–653
   Google Scholar
• Cohen A. J. Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food and Cosmetics Toxicology 1979; 17: 277–289
   PubMedGoogle Scholar
• Cox D., O'Kennedy R., Thornes R. D. The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone). Human Toxicology 1989; 8: 501–506
   PubMedGoogle Scholar
• Creaven P. J., Parke D. V., Williams R. T. A spectrofluorimetric study of the 7-hydroxylation of coumarin by liver microsomes. Biochemical Journal 1965; 96: 390–398
   PubMed Web of Science ®Google Scholar
• Dexeus F. H., Logothetis C. J., Sella A., Fitz K., Amato R., Reuben J. M., Dozier N. Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology 1990; 8: 325–329
   PubMed Web of Science ®Google Scholar
• Dominguez K., Fentem J. H., Garle M. J., Fry J. R. Comparison of Mongolian gerbil and rat hepatic microsomal monooxygenase activities: high coumarin 7-hydroxylase activity in the gerbil. Biochemical Pharmacology 1990; 39: 1629–1631
   PubMed Web of Science ®Google Scholar
• Egan D., O'Kennedy R., Moran E., Cox D., Prosser E., Thornes R. D. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metabolism Reviews 1990; 22: 503–529
   PubMed Web of Science ®Google Scholar
• Fentem J. H., Fry J. R. Comparison of the effects of inducers of cytochrome P450 on Mongolian gerbil and rat hepatic microsomal monooxygenase activities. Xenobiotica 1991; 21: 895–904
   PubMed Web of Science ®Google Scholar
• Fentem J. H., Garle M. J., Fry J. R. Effect of various inducers of cytochrome P450 on the metabolism of coumarin by rat liver microsomes: a previously unreported metabolite is the major component identified by h.p.l.c. Human and Experimental Toxicology 1990; 9: 329–330
   Google Scholar
• Fentem J. H., Fry J. R., Whiting D. A. o-Hydroxyphenylacetaldehyde: a major novel metabolite of coumarin formed by rat, gerbil and human liver microsomes. Biochemical and Biophysical Research Communications 1991; 179: 197–203
   PubMed Web of Science ®Google Scholar
• Fentem J. H., Fry J. R., Thomas N. W. Species differences in the hepatotoxicity of coumarin: a comparison of rat and Mongolian gerbil. Toxicology 1992; 71: 129–136
   PubMedGoogle Scholar
• Hazleton L. W., Tusing T. W., Zeitlin B. R., Thiessen R., Jr, Murer H. K. Toxicity of coumarin. Journal of Pharmacology and Experimental Therapeutics 1956; 118: 348–358
   PubMedGoogle Scholar
• Jamal S., Casley-Smith J. R., Casley-Smith J. R. The effects of 5,6-benzo[a]pyrone (coumarin) and DEC on filaritic lymphoedema and elephantiasis in India. Preliminary results. Annals of Tropical Medicine and Parasitology 1989; 83: 287–290
   PubMed Web of Science ®Google Scholar
• Kaighen M., Williams R. T. The metabolism of [3-14C] coumarin. Journal of Medicinal and Pharmaceutical Chemistry 1961; 3: 25–43
   Google Scholar
• Kaipainen P., Koivusaari U., Lang M. Catalytic and immunological comparisons of coumarin 7-hydroxylation in different species. Comparative Biochemistry and Physiology 1985; 81C: 293–296
   Google Scholar
• Kamath S. A., Narayan K. A. Interaction of Ca2+ with endoplasmic reticulum of rat liver: a standardised procedure for the isolation of rat liver microsomes. Analytical Biochemistry 1972; 48: 53–61
   PubMed Web of Science ®Google Scholar
• Kerékjártó B. Zur enzymatischen hydroxylierung von cumarin, I. Nachweis der reaktions-produkte und reaktionswege. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 1966; 345: 264–271
   PubMedGoogle Scholar
• Lake B. G., Gray T. J. B., Evans J. G., Lewis D. F. V., Beamand J. A., Hue K. L. Studies on the mechanism of coumarin-induced toxicity in rat hepatocytes: comparison with dihydrocoumarin and other coumarin metabolites. Toxicology and Applied Pharmacology 1989; 97: 311–323
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Marshall M. E., Butler K., Cantrell J., Wiseman C., Mendelsohn L. Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study. Cancer Chemotherapy and Pharmacology 1989; 24: 65–66
   PubMed Web of Science ®Google Scholar
• Marshall M. E., Butler K., Hermansen D. Treatment of hormone refractory stage D carcinoma of prostate with coumarin (1,2-benzopyrone) and cimetidine: a pilot study. Prostate 1990; 17: 95–99
   PubMed Web of Science ®Google Scholar
• Miles J. S., McLaren A. W., Forrester L. M., Glancey M. J., Lang M. A., Wolf C. R. Identification of the human liver cytochrome P450 responsible for coumarin 7-hydroxylase activity. Biochemical Journal 1990; 267: 365–371
   PubMed Web of Science ®Google Scholar
• Murayama M., Seto E., Okubo T., Morita I., Dobashi I., Maehara M. Synthetic studies on Suberosin and Osthol. Chemical and Pharmaceutical Bulletin 1972; 20: 741–746
   Google Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes, I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Opdyke D. L. J. Monographs on fragrance raw materials: coumarin. Food and Cosmetics Toxicology 1974; 12: 385–388
   PubMedGoogle Scholar
• Pelkonen O., Sotaniemi E. A., Ahokas J. T. Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons. British Journal of Clinical Pharmacology 1985; 19: 59–66
   PubMed Web of Science ®Google Scholar
• Peters M. M. C. G., Walters D. G., Van Ommen B., Van Bladeren P. J., Lake B. G. Effect of inducers of cytochrome P450 on the metabolism of [3-14C]coumarin by rat hepatic microsomes. Xenobiotica 1991; 21: 499–514
   PubMed Web of Science ®Google Scholar
• Raunio H., Syngelma T., Pasanen M., Juvonen R., Honkakoski P., Kairaluoma M. A., Sotaniemi E., Lang M. A., Pelkonen O. Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochemical Pharmacology 1988; 37: 3889–3895
   PubMed Web of Science ®Google Scholar
• Ritschel W. A., Hardt T. J. Pharmacokinetics of coumarin, 7-hydroxycoumarin and 7-hydroxycoumarin glucuronide in the blood and brain of gerbils following intraperitoneal administration of coumarin. Arzneimittel Forschung 1983; 33: 1254–1258
   PubMed Web of Science ®Google Scholar
• Shilling W. H., Crampton R. F., Longland R. C. Metabolism of coumarin in man. Nature 1969; 221: 664–665
   PubMed Web of Science ®Google Scholar
• Vande Casteele K., Geiger H., Van Sumere C. F. Separation of phenolics (benzoic acids, cinnamic acids, phenylacetic acids, quinic acid esters, benzaldehydes and acetophenones, miscellaneous phenolics) and coumarins by reversed-phase high-performance liquid chromatography. Journal of Chromatography 1983; 258: 111–124
   Web of Science ®Google Scholar
• Yamano S., Tatsuno J., Gonzalez F. J. The CYP2A3 gene product catalyses coumarin 7-hydroxylation in human liver microsomes. Biochemistry 1990; 29: 1322–1329
   PubMed Web of Science ®Google Scholar